Find clinical trials for Non-Hodgkin Lymphoma in Seattle, WA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Seattle, WA, USA:
SC262-101 is a Phase 1 study to evaluate SC262 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory bioma...
Phase 1
Seattle, Washington, United States and 2 other locations
CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...
Phase 1
Seattle, Washington, United States and 37 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Seattle, Washington, United States and 48 other locations
and to see how well it works in treating patients with B cell non-Hodgkin lymphoma that has come back (relapsed) or did no...
Phase 1, Phase 2
Seattle, Washington, United States
The main goal of this study is to show that people with certain immune problems (from Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-...
Phase 3
Tacoma, Washington, United States and 4 other locations
in participants with relapsed or refractory aggressive B-cell Non-Hodgkin's lymphoma. The study utilizes an optimized ster...
Phase 2
Tacoma, Washington, United States and 52 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...
Phase 2
Seattle, Washington, United States and 76 other locations
A Phase 1 Study Evaluating BAFFR-targeting CAR T Cells for Patients with Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma...
Phase 1
Seattle, Washington, United States and 5 other locations
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...
Phase 4
Seattle, Washington, United States and 34 other locations
and evaluate the preliminary anti-tumor activity of LTZ-301 administered as a single agent in adult subjects with relapsed or refractory B-cell non...
Phase 1
Seattle, Washington, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal